Drug intelligence / Profile preview

zhichi-shumian

Development stage: Unknown
Lead developer: Xiyuan Hospital
Administration: Oral

Overview

Zhichi-shumian is a traditional Chinese medicine (TCM) formulation, specifically a decoction or granules, being investigated for the treatment of chronic insomnia. It is particularly aimed at insomnia characterized by 'liver-qi stagnation' and 'heat disturbing the mind syndrome' according to TCM diagnostics. The drug is currently undergoing clinical trials to evaluate its efficacy and safety.

Other names: 栀豉舒眠方颗粒剂

Beyond the preview

Go deeper on zhichi-shumian.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on zhichi-shumian.

Explore the full profile